ACB
GRDN

Aristotle Capital Boston’s Guardian Pharmacy Services GRDN Stock Holding History

Aristotle Capital Boston’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.7M Sell
495,856
-93,159
-16% -$3.04M 1.16% 28
2025
Q4 		$17.7M Sell
589,015
-60,448
-9% -$1.71M 0.97% 41
2025
Q3 		$17M Buy
649,463
+239,790
+59% +$5.71M 0.88% 46
2025
Q2 		$8.73M Buy
+409,673
New +$9.24M 0.44% 83

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Aristotle Capital Boston's GRDN Position: Q1 2026 in Review

Aristotle Capital Boston reduced its Guardian Pharmacy Services (GRDN) stake by 16% in Q1 2026, selling an estimated $3.04M and leaving 495,856 shares worth $18.7M. The position accounts for 1.16% of the portfolio, ranked #28.

Aristotle Capital Boston first reported a position in GRDN in Q2 2025 and has held it in 4 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Aristotle Capital Boston held 495,856 shares of Guardian Pharmacy Services worth $18.7M as of Q1 2026.
  • Aristotle Capital Boston sold 93,159 Guardian Pharmacy Services shares in Q1 2026, an estimated $3.04M.
  • Guardian Pharmacy Services made up 1.16% of Aristotle Capital Boston's portfolio in Q1 2026, its #28 holding.
  • Aristotle Capital Boston first reported a position in Guardian Pharmacy Services in Q2 2025 and has held it in 4 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.